Transmission

The case presentation discussed in this 60-minute webinar provides insight on the complicated factors a nurse case manager navigated to treat a patient with disseminated TB. The webinar was created for TB nurses, nurse case managers, and public health nurses who manage TB patients.

This 75-minute webinar discusses TB and LTBI testing and treatment for international students in the university and college setting. The webinar includes information on updates to the American College Health Association (ACHA) TB guidelines, LTBI treatment options, and a model for LTBI screening and treatment in the University setting.

This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.

A checklist for individuals to see if they may need a test for TB. The checklist has 3 questions:

*Were you born in or have you lived in a country (for over a month) where TB is common? This includes anywhere in Africa, Asia, Mexico, Central or South America, the Caribbean or Eastern Europe.
*Have you lived with or spent time with someone who has had TB?
*Do you have HIV/AIDS, diabetes, or kidney disease? Are you an organ transplant recipient or do you take medication that weakens your immune system?

This information sheet summarizes the key findings of the new analysis of the CDC’s new estimates of the annual number of new HIV infections in the United States. The new analysis was published in the Morbidity and Mortality Weekly Report of September 12, 2008. The results of the analysis shows that among gay and bisexual men, young African Americans and Whites in their 30s and 40s are most affected, African American women are more affected than women of other races, and men account for the majority of new HIV infection among Hispanics/Latinos.

This pamphlet provides information about genital human papillomavirus (HPV). It notes that this is the most common sexually transmitted virus in the US and that most people who have the disease do not know it, as they may not have symptoms. It explains how the disease is transmitted, the symptoms and health effects of HPV, and focuses on important knowledge about HPV for both men and women. Women are warned that some types of HPV can cause cervical cancer in women, but that a woman can protect herself by getting regular Pap tests and early treatment for problems that could turn into cancer.

This pamphlet provides information about the STD chlamydia. It lists basic facts about the disease and discusses transmission, symptoms for men and women, testing, and treatment. The pamphlet explains that recent sex partners should be notified, as they would need to be tested for the disease and treated if infected. Chlamydia can be cured with antibiotic treatment, but an individual can be reinfected.

This report summarizes results of an investigation in which HCV was transmitted when a transplant facility mistakenly used a blood vessel conduit from an HCV-seropositive donor in a seronegative recipient in May 2009. In November of 2009, a second transplant facility identified two cases of potential hepatitis transmission from vessel conduits.

This MMWR report describes results of the Massachusetts Department of Public Health surveillance initiative to collect detailed information on hepatitis C virus (HCV) cases reported during 2007-2009 among 15-24-year olds, and to examine the data for trends through 2009. The results reveal the continued increase in rates of newly reported HCV infection among this age group. Cases were reported from all areas of the state, occurred predominantly among non-Hispanic white persons, and were equally distributed among male and females.

This article reports on a matched case-control study and viral analysis that examined the role of sexual transmission of Hepatics C virus (HCV) among HIV-infected men who have sex with men. In all, 22 case-patients and 53 control subjects were enrolled in the study. Participants completed self-administered questionnaires regarding sexual practices and drug-use behaviors during the 12 months preceding diagnosis or preceding the questionnaire.